HNRNPA2B1 and eosinophilia-myalgia syndrome: The lower expression levels of HNRNPA2B1 and HNRNPC were also associated with higher levels of enrichment for several other innate and adaptive immune cells in EU and EC samples; these dysregulated immune cells play a well-established role in the defective immunity of patients with EMs [38].